Literature DB >> 29017260

Waterpipe Use in the Middle East and North Africa: Data From the Breathe Study.

Ashraf Alzaabi1, Bassam Mahboub2, Hocine Salhi3, Wisco Kajingu4, Nauman Rashid5, Abdelkader El-Hasnaoui5.   

Abstract

INTRODUCTION: In recent decades, waterpipe use has gained popularity, notably in the Middle East and North Africa (MENA) region. This study describes waterpipe use and characteristics of waterpipe users among the general population of the MENA region.
METHODS: This study was a sub-analysis of the BREATHE study, a cross-sectional survey of chronic obstructive respiratory disease conducted in the general population of 11 countries of the MENA region. The study population consisted of subjects aged ≥40 years who completed the screening questionnaire and who reported waterpipe use (alone or with cigarettes). This questionnaire collected data on demographics, self-reported respiratory symptoms (breathlessness and productive cough), smoking habits (cigarettes or waterpipe) and diagnosis of chronic obstructive respiratory disease, chronic bronchitis or emphysema.
RESULTS: Of the 62 086 subjects screened in the BREATHE study, waterpipe use was reported by 2173 subjects (3.5% [95% CI: 3.4%-3.6%]), of whom 934 subjects (43.0%) smoked both waterpipes and cigarettes. The majority of waterpipe users were men (82%) and aged from 40 to 49 years (53.7%). Over 90% of users smoked their waterpipe for ≥1 hour per day. Waterpipe use was associated with an increased risk of productive cough (odds ratio [OR]: 1.49), breathlessness (OR: 1.33), and chronic bronchitis (OR: 1.43), independently of the risk associated with cigarette smoking. In subjects using waterpipe alone (N = 1239), breathlessness was the most frequently self-reported symptom (11.3%), followed by productive cough (6.0%) and chronic bronchitis (2.2%).
CONCLUSIONS: Waterpipe smoking in the region is widespread and is associated with an increased risk of respiratory pathology independently of cigarette smoking. IMPLICATIONS: This large general population study reports an elevated risk of respiratory disease associated with waterpipe use independently of cigarette smoking; this finding emphasizes the need for public health policies to curtail the growing spread of waterpipe use by young people in the MENA region.
© The Author 2016. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2017        PMID: 29017260     DOI: 10.1093/ntr/ntw256

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  4 in total

1.  Biochemical Data and Metabolic Profiles of Male Exclusive Narghile Smokers (ENSs) Compared With Apparently Healthy Nonsmokers (AHNSs).

Authors:  Yosra Hasni; Sabrine Bachrouch; Mohamed Mahjoub; Amel Maaroufi; Sonia Rouatbi; Helmi Ben Saad
Journal:  Am J Mens Health       Date:  2019 Jan-Feb

2.  Comparison of Periodontal Status Between Male Exclusive Narghile Smokers and Male Exclusive Cigarette Smokers.

Authors:  Mehdi Khemiss; Dalila Ben Fekih; Mohamed Ben Khelifa; Helmi Ben Saad
Journal:  Am J Mens Health       Date:  2019 Mar-Apr

3.  Cigarette smoking and smokeless tobacco use among male south Asian migrants in the United Arab Emirates: a cross-sectional study.

Authors:  Raghib Ali; Tom Loney; Mohammed Al-Houqani; Iain Blair; Faisal Aziz; Salma Al Dhaheri; Iffat El Barazi; Elpidoforos S Soteriades; Syed M Shah
Journal:  BMC Public Health       Date:  2020-05-30       Impact factor: 3.295

Review 4.  Joint statement for the diagnosis, management, and prevention of chronic obstructive pulmonary disease for Gulf Cooperation Council countries and Middle East-North Africa region, 2017.

Authors:  Bassam H Mahboub; Mayank Gian Vats; Ashraf Al Zaabi; Mohammed Nizam Iqbal; Tarek Safwat; Fatma Al-Hurish; Marc Miravitlles; Dave Singh; Khaled Asad; Salah Zeineldine; Mohamed S Al-Hajjaj
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.